Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD

REFERENCES

• van Rood J, van Leeuwen A, van Santen M: Anti HL-A2 inhibitor in normal human serum. Nature. 1970;226:366–367.
   PubMed Web of Science ®Google Scholar
• Zavazava N: Soluble HLA class I molecules: biological significance and clinical implications. Mol Med Today. 1998;4:116–121.
   PubMedGoogle Scholar
• Billing R, Safani M, Peterson P: Soluble HLA antigens present in normal human serum. Tissue Antigens. 1977;10:75–82.
   PubMed Web of Science ®Google Scholar
• Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature. 1999;401:921–923.
   PubMed Web of Science ®Google Scholar
• Pujo-Borrell R, Hanafusa T, Chiovato L, Bottazzo GF: Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature. 1983;304:71–73.
   PubMed Web of Science ®Google Scholar
• Adamashvili I, McDonald J, Fraser P, Milford EL, Pressly TA, Gelder FB: Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol. 1995;22:1025–1031.
   PubMed Web of Science ®Google Scholar
• Tsuchiya N, Shiota M, Yamaguchi A, Ito K: Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum. 1996;39:792–796.
   PubMed Web of Science ®Google Scholar
• Zavazava N, Böttcher H, Ruchholtz W: Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens. 1993;42:20–26.
   PubMed Web of Science ®Google Scholar
• Puppo F, Pellicci R, Brenci S, Nocera A, Morelli N, Dardano G, Bertocchi M, Antonucci A, Ghio M, Scudeletti M, Barocci S, Valente U, Indiveri F: HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol. 1994;40:166–170.
   PubMed Web of Science ®Google Scholar
• Puppo F, Scudeletti M, Indiveri F, Ferrone S: Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today. 1995;16:124–127.
   PubMedGoogle Scholar
• Nocito M, Montalbán C, González-Porque P, Villar LM: Increased soluble serum HLA class I antigens in patients with lymphoma. Hum Immunol. 1997;58:106–111.
   PubMed Web of Science ®Google Scholar
• Shimura T, Tsutsumi S, Hosouchi Y, Kojima T, Kon Y, Yonezu M, Kuwano H: Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer. Hum Immunol. 2001;62:615–619.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Rebmann V, Neubert A, Plewa S, Ferencik S, Vögeler U, Steuhl KP, Grosse-Wilde H: Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis. Tissue Antigens. 2004;63:369–375.
   PubMed Web of Science ®Google Scholar
• Stewart G, McLeod J, Basten A, Bashir HV: HLA family studies and multiple sclerosis: a common gene, dominantly expressed. Hum Immunol. 1981;3:13–29.
   PubMed Web of Science ®Google Scholar
• Tjernstrom F, Hellmer G, Nived O, Truedsson L, Sturfelt G: Synergistic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17, DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus. 1999;8:103–108.
   PubMed Web of Science ®Google Scholar
• Doherty DG, Donaldson PT, Whitehouse DB, Mieli-Vergani G, Duthrie A, Hopkinson DA, Mowat AP: HLA phenotypes and gene polymorphisms in juvenile liver disease associated with alpha 1-antitrypsin deficiency. Hepatology. 1990;12:218–223.
   PubMed Web of Science ®Google Scholar
• Kueppers F, Christopherson MJ: Alpha1-antitrypsin: further genetic heterogeneity revealed by isoelectric focusing. Am J Hum Genet. 1978;30:359–365.
   PubMed Web of Science ®Google Scholar
• Casavilla A, Gordon R, van Thiel DH, Starzl TE: Lack of association between HLA antigen DR3 and alpha 1-antitrypsin deficiency in liver transplant recipients. Dig Dis Sci. 1993;38:1489–1491.
   PubMed Web of Science ®Google Scholar
• D'Ortho M, Jarreau P, Delacourt C, Macquin-Mavier I, Levame M, Pezet S, Harf A, Lafuma C: Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol. 1994;2663:L209–L216.
   Google Scholar
• Bergin DA, Reeves EP, Meleady P, Henry M, McElvaney OJ, Carroll TP, Condron C, Chotirmall SH, Clynes M, O'Neill SJ, McElvaney NG: α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest. 2010;120:4236–4250.
   PubMed Web of Science ®Google Scholar
• Churg A, Wang X, Wang RD, Meixner SC, Pryzdial EL, Wright JL: Alpha-1 antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol. 2007;37:144–151.
   PubMed Web of Science ®Google Scholar
• Demaria S, Schwab R, Gottesman S, Bushkin Y: Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem. 1994;269:6689–6694.
   PubMed Web of Science ®Google Scholar
• Aultman D, Adamashvili I, Yaturu K, Langford M, Gelder F, Gautreaux M, Ghali GE, McDonald J: Soluble HLA in human body fluids. Hum Immunol. 1999;60:239–244.
   PubMed Web of Science ®Google Scholar
• Filaci G, Contini P, Brenci S, Lanza L, Scudeletti M, Indiveri F, Puppo F: Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens. 1995;46:117–123.
   PubMed Web of Science ®Google Scholar
• Stevenson F, George A, Walters M, Hamblin TJ: Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J Immunol Methods. 1986;86:187–190.
   PubMed Web of Science ®Google Scholar
• Filaci G, Contini P, Brenci S, Gazzola P, Lanza L, Scudeletti M, Indiveri F, Mancardi GL, Puppo F: Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Hum Immunol. 1997;54:54–62.
   PubMed Web of Science ®Google Scholar